FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlo Torti

Research Profile

Disorders

HIV Infections

Procedures

Chemicals & Drugs

Living Beings

HIV-1

Concepts & Ideas

Physiology

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
A Ferraresi; A Calabresi; F Castelli; Filippo Castelnuovo; A Scalzini; Carlo Torti; A Vavassori; E Quiros-Roldan
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009.
Manuela Colafigli; Paola Corsi; Simona Di Giambenedetto; Angela Gonnelli; Nino Manca; V Micheli; Laura Monno; Giustino Parruti; Giovanni Penco; Grazia Punzi; A Rosi; Carlo Torti; Enrico Maria Trecarichi; L Albini; Patrizia Bagnarelli; Bianca Bruzzone; Roberto Cauda
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlo Torti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
The Journal of infectious diseases 2013;207(8):1216-20.
2012: A Ferraresi; A Calabresi; F Castelli; Filippo Castelnuovo; A Scalzini; Carlo Torti; A Vavassori; E Quiros-Roldan
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009.
International journal of STD & AIDS 2012;23(10):753-5.
2012: Manuela Colafigli; Paola Corsi; Simona Di Giambenedetto; Angela Gonnelli; Nino Manca; V Micheli; Laura Monno; Giustino Parruti; Giovanni Penco; Grazia Punzi; A Rosi; Carlo Torti; Enrico Maria Trecarichi; L Albini; Patrizia Bagnarelli; Bianca Bruzzone; Roberto Cauda
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(8):E299-304.
2012: Carlo Torti; Giampiero Carosi; Emanuele Focà; Daria Gotti; Roberto Maroldi; Gherardo Mazziotti; Pier Antonio Soldini; Andrea Giustina
High prevalence of radiological vertebral fractures in HIV-infected males.
Endocrine 2012;41(3):512-7.
2012: Carlo Torti; S L Caputo; Giuliana Cologni; S Digiambenedetto; Issa El Hamad; M Fabbiani; Nicoletta Ladisa; Franco Maggiolo; D Motta; Giuseppe Paraninfo; Mattia Prosperi; Eugenia Quiros-Roldan; Diego Ripamonti; Laura Sighinolfi; I Frank
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(5):449-58.
2012: Carlo Torti; Mirko Paiardini; Andrea Gori
Immunity to human immunodeficiency virus (HIV) infection.
Clinical & developmental immunology 2012;2012():629356.
2012: Davide Motta; Paola Nasta; Laura Sighinolfi; Nigritella Brianese; Filippo Castelnuovo; Giuliana Cologni; Silvia Costarelli; Simona Di Giambenedetto; Massimo Di Pietro; Massimiliano Fabbiani; Emanuele Focà; Nicoletta Ladisa; Franco Maggiolo; Carlo Torti
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received.
AIDS research and therapy 2012;9(1):18.
2011: Andrea Gori; Jan Knol; Tiziana Quirino; Giuliano Rizzardini; Camilla Tincati; Carlo Torti; Daria Trabattoni; J van Schaik; Belinda van't Land; A Vriesema; Gjalt W Welling; K B Amor; Alessandra Bandera; K Benlhassan-Chahour; D Bray; J Garssen; M Clerici
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial.
Mucosal immunology 2011;4(5):554-63.
2011: Monia Mendeni; Emanuele Focà; Daria Gotti; Nicoletta Ladisa; Gioacchino Angarano; Laura Albini; Filippo Castelnuovo; Giampiero Carosi; Eugenia Quiros-Roldan; Carlo Torti
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(9):1164-73.
2011: Carlo Torti; Bruno M Cesana; Emanuele Focà; Francois X Lescure
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
BMC medicine 2011;9():138.
2011: Ilaria Izzo; Maria A Forleo; Salvatore Casari; Eugenia Quiros-Roldan; Michele Magoni; Giampiero Carosi; Carlo Torti
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy).
BMC public health 2011;11():124.
2011: Daria Gotti; Emanuele Focà; Laura Albini; Monia Mendeni; Andrea Vavassori; Eugenia Quiros Roldan; Carlo Torti
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules.
Current HIV research 2011;9(1):61-9.
2010: Eugenia Quiros-Roldan; Silvia Amadasi; Giuseppe Paraninfo; Ilaria Izzo; Roberto Allegri; Davide Motta; Francesca Gatti; Graziella Cristini; Giampiero Carosi; Monia Mendeni; Carlo Torti
The impact of gender and anchor drugs on TDF renal toxicity.
Journal of acquired immune deficiency syndromes (1999) 2010;55(2):e11-2.
2008: Carlo Torti; Ian Frank
A king in the CASTLE? Optimum initial HIV protease inhibitor.
Lancet 2008;372(9639):604-6.
2008: Silvia Costarelli; Carlo Torti; Anna Rodella; Fausto Baldanti; Stefania Paolucci; Giuseppe Lapadula; Nino Manca; Eugenia Quiros-Roldan; Ilaria Izzo; Giampiero Carosi
Screening and Management of HIV-2-Infected Individuals in Northern Italy.
AIDS patient care and STDs 2008;22(6):489-94.
2008: Giuseppe Lapadula; Ilaria Izzo; Franco Gargiulo; Giuseppe Paraninfo; Filippo Castelnuovo; Eugenia Quiros-Roldan; Giuliana Cologni; Francesca Ceresoli; Nino Manca; Giampiero Carosi; Carlo Torti
Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysis.
Journal of medical virology 2008;80(5):747-53.
2008: Nicola Squillace; Giuseppe Lapadula; Carlo Torti; Gabriella Orlando; S Mandalia; Giulia Nardini; Barbara Beghetto; Silvia Costarelli; Giovanni Guaraldi
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study.
HIV medicine 2008;9(3):151-9.
2008: Andrea Gori; Camilla Tincati; Giuliano Rizzardini; Carlo Torti; Tiziana Quirino; Monique Haarman; kaouther ben amor; Jacqueline van Schaik; Aldwin Vriesema; Jan Knol; Giulia Marchetti; Gjalt W Welling; Mario Clerici
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis.
Journal of clinical microbiology 2008;46(2):757-8.
2008: Giuseppe Lapadula; Alessandra Calabresi; Filippo Castelnuovo; Silvia Costarelli; Eugenia Quiros-Roldan; Giuseppe Paraninfo; Francesca Ceresoli; Franco Gargiulo; Nino Manca; Giampiero Carosi; Carlo Torti
Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.
Antiviral therapy 2008;13(4):601-5.
2008: Eugenia Quiros-Roldan; Alessandra Calabresi; Giuseppe Lapadula; Valeria Tirelli; Silvia Costarelli; Giuliana Cologni; Serena Zaltron; Massimo Puoti; Giampiero Carosi; Carlo Torti
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Antiviral therapy 2008;13(3):341-8.
2008: Carlo Torti; Maria Eugenia Quiros-Roldan; Giuliana Cologni; Michele Nichelatti; Francesca Ceresoli; Marcello Pinti; Milena Nasi; Andrea Cossarizza; Giuseppe Lapadula; Silvia Costarelli; Nino Manca; Franco Gargiulo; Michele Magoni; Giampiero Carosi
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals.
Current HIV research 2008;6(1):43-8.
2007: Marco Bongiovanni; Nicola Gianotti; Elisabetta Chiesa; Paola Nasta; Paola Cicconi; Amedeo Capetti; Antonio Di Biagio; A Matti; Valeria Tirelli; P Marconi; Andrea De Luca; Cristina Mussini; Fulvio Gatti; Mauro Zaccarelli; C Abeli; Carlo Torti; Andrea Antinori; Antonella Castagna; Antonella d'Arminio Monforte
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
Infection 2007;35(6):451-6.
2007: Silvia Costarelli; Carlo Torti; Luisa Benerini Gatta; Carmine Tinelli; Giuseppe Lapadula; Eugenia Quiros-Roldan; Ilaria Izzo; Filippo Castelnuovo; Giorgio Biasiotto; Paolo Arosio; Giampiero Carosi
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients.
Journal of acquired immune deficiency syndromes (1999) 2007;46(2):255-6.
2007: Eugenia Quiros-Roldan; Valeria Tirelli; Carlo Torti; Elena Sosta; Cinzia Tosoni; Ezio Damiolini; Giampiero Carosi
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide.
AIDS (London, England) 2007;21(10):1388-9.
2007: Giampiero Carosi; Eugenia Quiros-Roldan; Carlo Torti; Andrea Antinori; M Bevilacqua; R C Bonadonna; Paolo Bonfanti; Antonella Castagna; R Cauda; Antonella d'Arminio Monforte; P Di Gregorio; G Di Perri; R Esposito; F Fatuzzo; Cristina Gervasoni; C Giannattasio; G Guaraldi; A Lazzarin; Sergio Lo Caputo; Paolo Maggi; Francesco Mazzotta; M Moroni; T Prestileo; R Ranieri; Giuliano Rizzardini; R Russo; M Galli
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
Infection 2007;35(3):134-42.
2007: Carlo Torti; Giuseppe Lapadula; Pablo Barreiro; Vicente Soriano; Sundhiya Mandalia; Annalisa De Silvestri; Fredy Suter; Franco Maggiolo; Andrea Antinori; Francesco Antonucci; Renato Maserati; Issa El Hamad; Piera Pierotti; Laura Sighinolfi; Guglielmo Migliorino; Nicoletta Ladisa; Giampiero Carosi
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
The Journal of antimicrobial chemotherapy 2007;59(6):1141-7.
2007: Carlo Torti; Giuseppe Lapadula; Franco Maggiolo; Salvatore Casari; Fredy Suter; Lorenzo Minoli; Chiara Pezzoli; Massimo Di Pietro; Guglielmo Migliorino; Eugenia Quiros-Roldan; Nicoletta Ladisa; Laura Sighinolfi; Francesca Gatti; Giampiero Carosi
Predictors of AIDS-defining events among advanced naïve patients after HAART.
HIV clinical trials 2007;8(3):112-20.
2007: Eugenia Quiros-Roldan; Carlo Torti; Giuseppe Lapadula; Nicoletta Ladisa; Valeria Micheli; Andrea Patroni; Maria Cusato; Piera Pierotti; Valeria Tirelli; Maria Cristina Uccelli; Simona Di Giambenedetto; Filippo Castelnuovo; Franco Gargiulo; Nino Manca; Giampiero Carosi
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.
AIDS patient care and STDs 2007;21(2):92-9.
2007: Carlo Torti; Giuseppe Lapadula; Maria Cristina Uccelli; Eugenia Quiros-Roldan; Mario Regazzi; Nicoletta Ladisa; Valeria Micheli; Anna Orani; Andrea Patroni; Sergio Lo Caputo; Valeria Tirelli; Simona Di Giambenedetto; Giuliana Cologni; Silvia Costarelli; Franco Gargiulo; Nino Manca; Giampiero Carosi
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
International journal of antimicrobial agents 2007;29(2):185-90.
2007: Carlo Torti; Silvia Costarelli; Annalisa De Silvestri; Eugenia Quiros-Roldan; Giuseppe Lapadula; Giuliana Cologni; Giuseppe Paraninfo; Filippo Castelnuovo; Massimo Puoti; Giampiero Carosi
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(12):1161-9.
2007: Giuseppe Lapadula; Carlo Torti; Franco Maggiolo; Salvatore Casari; Fredy Suter; Lorenzo Minoli; Chiara Pezzoli; Massimo Di Pietro; Guglielmo Migliorino; Eugenia Ouiros-Roldan; Nicoletta Ladisa; Laura Sighinolfi; Silvia Costarelli; Giampiero Carosi
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Antiviral therapy 2007;12(6):941-7.
2007: Giuseppe Lapadula; Ilaria Izzo; Silvia Costarelli; Giuliana Cologni; Luisa Bercich; Salvatore Casari; Marco Gambarotti; Carlo Torti
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report.
Journal of medical case reports 2007;1():19.
2006: Nicola Gianotti; Vincenzo Mondino; Maria Cristina Rossi; Elisabetta Chiesa; Ivano Mezzaroma; Nicoletta Ladisa; Giovanni Guaraldi; Carlo Torti; Pierluigi Tarquini; Paula Castelli; Aldo Di Carlo; Enzo Boeri; Wilco Keulen; Paula Mc Kenna; Adriano Lazzarin
Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(10):1470-80.
2006: Carlo Torti; Maria Cristina Uccelli; Eugenia Quiros-Roldan; Franco Gargiulo; Valeria Tirelli; Giuseppe Lapadula; Mario Regazzi; Piera Pierotti; Carmine Tinelli; Andrea De Luca; Andrea Patroni; Nino Manca; Giampiero Carosi
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):414-9.
2006: Carlo Torti; Giuseppe Lapadula; Massimo Puoti; Salvatore Casari; Maria Cristina Uccelli; Graziella Cristini; Daniele Bella; Giuseppe Pastore; Nicoletta Ladisa; Lorenzo Minoli; Giovanni Sotgiu; Sergio Lo Caputo; Stefano Bonora; Giampiero Carosi
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):180-5.
2006: Franco Maggiolo; Diego Ripamonti; Carlo Torti; Claudio Arici; Andrea Antinori; Eugenia Quiros-Roldan; Lorenzo Minoli; Laura Sighinolfi; Paola Nasta; Fredy Suter
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.
Antiviral therapy 2006;11(7):923-9.
2006: Giuseppe Lapadula; Carlo Torti; Giuseppe Paraninfo; Filippo Castelnuovo; Maria Cristina Uccelli; Silvia Costarelli; Nicoletta Ladisa; Renato Maserati; Massimo Di Pietro; Annalisa De Silvestri; Carmine Tinelli; Massimo Puoti; Giampiero Carosi
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.
Antiviral therapy 2006;11(4):521-7.
2006: Maria Cristina Uccelli; Carlo Torti; Giuseppe Lapadula; Lorena Labate; Giuliana Cologni; Valeria Tirelli; Francesca Moretti; Silvia Costarelli; Eugenia Quiros-Roldan; Giampiero Carosi
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART.
Annals of nutrition & metabolism 2006;50(3):247-52.
2006: Annalisa Saracino; Laura Monno; Luigia Scudeller; Donatella Concetta Cibelli; Alessandra Tartaglia; Grazia Punzi; Carlo Torti; Sergio Lo Caputo; Francesco Mazzotta; Gaetano Scotto; Giampiero Carosi; Gioacchino Angarano
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors.
Journal of medical virology 2006;78(1):9-17.
2005: Raffaele Badolato; R Fabian Schumacher; Elisabetta Rodella; Franco Gargiulo; Carlo Torti; Luigi D Notarangelo; Marzia Duse
Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens.
The Pediatric infectious disease journal 2005;24(8):747-9.
2005: Giampiero Carosi; Massimo Puoti; Giovanni Antonucci; Andrea De Luca; Renato Maserati; Carlo Torti; Paolo Bonfanti; Stefano Bonora; RAFFAELE BRUNO; Giovanni B Gaeta; Andrea Antinori; Antonella d'Arminio Monforte; Anna Orani; evangelista sagnelli; Antonietta Cargnel; Roberto Cauda; Francesco Mazzotta; Giuseppe Pastore; Fredy Suter; Vincenzo Vullo
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
AIDS reviews 2005;7(3):161-7.
2005: Carlo Torti; Franco Maggiolo; Andrea Patroni; Fredy Suter; Nicoletta Ladisa; Giuseppe Paraninfo; Piera Pierotti; Anna Orani; Lorenzo Minoli; Claudio Arici; Laura Sighinolfi; Carmine Tinelli; Giampiero Carosi
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
The Journal of antimicrobial chemotherapy 2005;56(1):190-5.
2005: Carlo Torti; Eugenia Quiros-Roldan; Mario Regazzi; Andrea De Luca; Francesco Mazzotta; Andrea Antinori; Nicoletta Ladisa; Valeria Micheli; Anna Orani; Andrea Patroni; Paola Villani; Sergio Lo Caputo; Francesca Moretti; Simona Di Giambenedetto; Filippo Castelnuovo; Paolo Maggi; Carmine Tinelli; Giampiero Carosi
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(12):1828-36.
2005: Eugenia Quiros-Roldan; Francesca Moretti; Carlo Torti; Valeria Tirelli; Roberto Stellini; Silvia Pirovano; Giampiero Carosi; Luisa Imberti
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(6):436-7.
2005: Eugenia Quirós-Roldán; Carlo Torti; Giampiero Carosi
[Usefulness of pharmacokinetics in the management of antiretroviral therapy].
Medicina clínica 2005;124(18):695-6.
2005: Carlo Torti; Eugenia Quiros-Roldon; Mario Regazzi; Andrea Antinori; Andrea Patroni; Paola Villani; Valeria Tirelli; Giuliana Cologni; Daniela Zinzi; Sergio Lo Caputo; Paolo Perini; Giampiero Carosi
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy.
Antiviral therapy 2005;10(4):505-13.
2005: Carlo Torti; Giuseppe Lapadula; Salvatore Casari; Massimo Puoti; Mark Nelson; Eugenia Quiros-Roldan; Daniele Bella; Giuseppe Pastore; Nicoletta Ladisa; Lorenzo Minoli; Giovanni Sotgiu; Francesco Mazzotta; Sergio Lo Caputo; Giovanni Di Perri; Gaetano Filice; Carmine Tinelli; Giampiero Carosi
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
BMC infectious diseases 2005;5():58.
2005: Eugenia Quiros-Roldan; Carlo Torti; Carmine Tinelli; Francesca Moretti; Barbara Zanini; Valeria Tirelli; A Pan; Salvatore Casari; Giampiero Carosi
Risk factors for myocardial infarction in HIV-positive patients.
International journal of STD & AIDS 2005;16(1):14-8.
2005: Eugenia Quiros-Roldan; Francesca Moretti; Carlo Torti; Valeria Tirelli; Salvatore Casari; Giampiero Carosi
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir-containing regimens.
Journal of clinical laboratory analysis 2005;19(1):26-9.
2004: Annalisa Saracino; Laura Monno; Sergio Locaputo; Carlo Torti; Luigia Scudeller; Nicoletta Ladisa; Andrea Antinori; Laura Sighinolfi; Antonio Chirianni; Francesco Mazzotta; Giampiero Carosi; Gioacchino Angarano
Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1587-98.
2004: Carlo Torti; Eugenia Quiros-Roldan; Valeria Tirelli; M Regazzi-Bonora; Francesca Moretti; Piera Pierotti; Anna Orani; Paolo Maggi; Antonietta Cargnel; Andrea Patroni; Andrea De Luca; Giampiero Carosi
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients.
AIDS patient care and STDs 2004;18(11):629-34.
2004: Carlo Torti; L Bono; Franco Gargiulo; Maria Cristina Uccelli; Eugenia Quiros-Roldan; Andrea Patroni; Giuseppe Paraninfo; Valeria Tirelli; Nino Manca; Maria Antonia De Francesco; Francesca Perandin; Giampiero Carosi
Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(9):826-30.
2004: Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saracino; Gioacchino Angarano; Carmine Tinelli; Sergio Lo Caputo; Valeria Tirelli; Francesco Mazzotta; Giampiero Carosi
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.
Journal of medical virology 2004;74(1):29-33.
2004: Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saracino; Gioacchino Angarano; Carmine Tinelli; Francesco Mazzotta; Sergio Lo Caputo; Piera Pierotti; Giampiero Carosi
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1104-7.
2004: Eugenia Quirós-Roldán; Carlo Torti; Giampiero Carosi
[The novel non-A, non-E hepatitis viruses and their pathogenic effect].
Medicina clínica 2004;122(14):552-4.
2004: Carlo Torti; Eugenia Quiros-Roldan; Mario Regazzi-Bonora; Andrea De Luca; Sergio Lo Caputo; Simona Di Giambenedetto; Andrea Patroni; Paola Villani; Valeria Micheli; Giampiero Carosi
Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):324-6.
2004: Carlo Torti; Eleanor Barnes; Eugenia Quiros-Roldan; Massimo Puoti; Giampiero Carosi; Paul Klenerman
Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
Antiviral therapy 2004;9(1):139-42.
2004: Eugenia Quiros-Roldan; Carlo Torti; Silvia Pirovano; Francesca Moretti; Salvatore Casari; Giampiero Carosi; Vicente Soriano; Luisa Imberti
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target?
Intervirology 2004;47(6):350-4.
2004: Carlo Torti; Giuliana Cologni; Maria Cristina Uccelli; Eugenia Quiros-Roldan; Luisa Imberti; Paolo Airó; Silvia Pirovano; Andrea Patroni; Valeria Tirelli; Giampiero Carosi
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).
Viral immunology 2004;17(2):279-86.
2003: Eugenia Quiros-Roldan; Carlo Torti; Luisa Imberti; Salvatore Casari; Vicente Soriano; Francesca Moretti; Silvia Pirovano; Giampiero Carosi
SENV infection in HIV-positive patients: prevalence, subtype characterization, and impact on HIV disease progression.
AIDS research and human retroviruses 2003;19(12):1079-82.
2003: Luigia Scudeller; Carlo Torti; Eugenia Quiros-Roldan; Andrea Patroni; Sergio Lo Caputo; Francesca Moretti; Francesco Mazzotta; Elisa Donati; Angela Vivarelli; Giampiero Carosi
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations.
The Journal of antimicrobial chemotherapy 2003;52(5):776-81.
2003: Lina Tomasoni; Andrea Patroni; Carlo Torti; Giuseppe Paraninfo; Franco Gargiulo; Eugenia Quiros-Roldan; Maria Cristina Uccelli; Paolo Airò; Carmine Tinelli; Giampiero Carosi; Francesco Castelli
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.
HIV clinical trials 2003;4(5):311-23.
2003: Carlo Torti; Salvatore Casari; Loredana Palvarini; Eugenia Quiros-Roldan; Francesca Moretti; Luigi Leone; Andrea Patroni; Francesco Castelli; Diego Ripamonti; Andrea Tramarin; Giampiero Carosi
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting.
Health policy (Amsterdam, Netherlands) 2003;65(3):261-7.
2003: Carlo Torti; Eugenia Quiros-Roldan; Wilco Keulen; Luigia Scudeller; Sergio Lo Caputo; Charles Boucher; Francesco Castelli; Francesco Mazzotta; Piera Pierotti; Anne Mieke Been-Tiktak; Giovanni Buccoliero; Michele De Gennaro; Giampiero Carosi; Carmine Tinelli
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients.
The Journal of infectious diseases 2003;188(2):194-201.
2003: Carlo Torti; Eugenia Quiros-Roldan; Luigia Scudeller; Sergio Lo Caputo; Lina Tomasoni; Francesco Castelli; A Poggio; P Delle Foglie; Antonio Chirianni; Laura Sighinolfi; Francesco Mazzotta; Giampiero Carosi
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study.
HIV medicine 2003;4(3):263-70.
2003: Eugenia Quiros-Roldan; Francesca Moretti; Carlo Torti; Salvatore Casari; F Castelli; A Beltrame; G Carosi
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital.
Infection 2003;31(3):172-3.
2003: Carlo Torti; Francesca Moretti; Maria Cristina Uccelli; Valeria Tirelli; Eugenia Quiros-Roldan; Franco Gargiulo; Giampiero Carosi
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(4):CS16-9.
2003: Francesco Mazzotta; Sergio Lo Caputo; Carlo Torti; Carmine Tinelli; Piera Pierotti; Francesco Castelli; Adriano Lazzarin; Gioacchino Angarano; Renato Maserati; Nicola Gianotti; Nicoletta Ladisa; Eugenia Quiros-Roldan; Alex R Rinehart; Giampiero Carosi
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.
Journal of acquired immune deficiency syndromes (1999) 2003;32(3):268-80.
2003: Massimo Puoti; Carlo Torti; Diego Ripamonti; Francesco Castelli; Serena Zaltron; Barbara Zanini; Angiola Spinetti; Valeria Putzolu; Salvatore Casari; Lina Tomasoni; Eugenia Quiros-Roldan; Maurizio Favret; Luisa Berchich; Piergiovanni Grigolato; Francesco Callea; Giampiero Carosi
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.
Journal of acquired immune deficiency syndromes (1999) 2003;32(3):259-67.
2003: Maria Cristina Uccelli; Carlo Torti; Eugenia Quiros-Roldan; Carmine Tinelli; Andrea Patroni; Francesco Castelli; Giampiero Carosi; Paolo Airò
Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy.
AIDS (London, England) 2003;17(1):141-3.
2002: Andrea Patroni; Carlo Torti; Lina Tomasoni; Eugenia Quiros Roldan; Davide Bertelli; Massimo Puoti; Gian Pietro Cadeo; Intissar Sleiman; Carmine Tinelli; Giampiero Carosi; Francesco Castelli
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
HIV clinical trials 2002;3(6):451-61.
2002: Lina Tomasoni; Andrea Patroni; Maria Cristina Uccelli; Franco Gargiulo; Carlo Torti; Giampiero Carosi; Francesco Castelli
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound.
The Journal of infectious diseases 2002;186(3):445-6.
2002: Eugenia Quiros-Roldan; M Carmen Maroto; Carlo Torti; Francesca Moretti; Salvatore Casari; Angelo Pan; Giampiero Carosi
No evidence of benefical effect of GB virus type C infection on the course of HIV infection.
AIDS (London, England) 2002;16(10):1430-1.
2002: Carlo Torti; Andrea Patroni; Carmine Tinelli; Intissar Sleiman; Eugenia Quiros-Roldan; Massimo Puoti; Francesco Castelli
Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;29(3):315-7.
2002: Eugenia Quirós-Roldán; Carlo Torti; Angelo Pan; Giampiero Carosi
[New strategies and new drugs in the salvage therapy for HIV infection].
Medicina clínica 2002;118(6):222-4.
2002: Eugenia Quiros-Roldan; Monica Airoldi; Francesca Moretti; Caterina Fausti; Angelo Pan; Salvatore Casari; Carlo Torti; Francesco Castelli; Giampiero Carosi
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy.
Journal of clinical laboratory analysis 2002;16(2):76-8.
2001: Eugenia Quiros-Roldan; Davide Bertelli; S Signorini; Monica Airoldi; Carlo Torti; Francesca Moretti; Giampiero Carosi
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment.
Microbios 2001;106(414):137-45.
2001: Eugenia Quiros-Roldan; S Signorini; Francesco Castelli; Carlo Torti; Andrea Patroni; Monica Airoldi; Giampiero Carosi
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.
Journal of clinical laboratory analysis 2001;15(1):43-6.
2000: Paolo Airò; Carlo Torti; Maria Cristina Uccelli; Fabio Malacarne; Loredana Palvarini; Giampiero Carosi; Francesco Castelli
Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
AIDS research and human retroviruses 2000;16(17):1805-7.
1999: Giampiero Carosi; Carlo Torti; Loredana Palvarini; Eugenia Quiros Roldan
HIV-1 pharmacoresistance: clinical and therapeutic implications.
Journal of biological regulators and homeostatic agents 1999;13(3):163-71.